Richard Granneman
- Virology top 5%
- HIV Research and Treatment 6
- Infectious Diseases top 5%
- HIV/AIDS drug development and treatment 9
- HIV/AIDS Research and Interventions 4
-
- Pharmacological Effects and Toxicity Studies 5
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism 2
- Clinical Biochemistry top 10%
-
- Epilepsy research and treatment 2
-
- Drug Transport and Resistance Mechanisms 2
-
- Adenosine and Purinergic Signaling 1
- Co-authors
- Joseph M. MachinistJ. W. KestersonEmil SamaraAnn HsuJohn M. LeonardAllen CatoJohn H. CavanaughDavid D. Ho
- Journals
- Hepatology (2 papers)Antimicrobial Agents and Chemotherapy (2 papers)Clinical Pharmacology & Therapeutics (5 papers)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Richard Granneman
16 papers receiving 657 citations
Peers
Comparison fields: 5 of 75
- Virology 190
- Infectious Diseases 331
- Pediatrics, Perinatology and Child Health 277
- Pharmacology 113
- Clinical Biochemistry 64
Countries citing papers authored by Richard Granneman
This map shows the geographic impact of Richard Granneman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Granneman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Granneman more than expected).
Fields of papers citing papers by Richard Granneman
This network shows the impact of papers produced by Richard Granneman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Granneman. The network helps show where Richard Granneman may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Richard Granneman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 10 | |
| 2 | 2005 | 6 | |
| 3 | Assessment of the steady-state pharmacokinetic interaction of lopinavir/ritonavir with either indinavir or saquinavir in healthy subjects | 2002 | 5 |
| 4 | 1999 | 157 | |
| 5 | 1998 | 54 | |
| 6 | 1998 | 10 | |
| 7 | 1998 | 19 | |
| 8 | 1997 | 32 | |
| 9 | 1997 | 57 | |
| 10 | Evaluation of the effect of fluconazole on the pharmacokinetics of ritonavir. | 1997 | 23 |
| 11 | 1997 | 5 | |
| 12 | 1996 | 2 | |
| 13 | 1996 | 5 | |
| 14 | 1996 | 0 | |
| 15 | 1995 | 18 | |
| 16 | The influence of temafloxacin and ciprofloxacin on the elimination of caffeine in human volunteers | 1991 | 2 |
| 17 | 1984 | 60 | |
| 18 | 1984 | 212 |
About Richard Granneman
Richard Granneman is a scholar working on Virology, Infectious Diseases and Pediatrics, Perinatology and Child Health, having authored 18 papers that have together received 677 indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (9 papers), HIV Research and Treatment (6 papers), Pharmacological Effects and Toxicity Studies (5 papers), HIV/AIDS Research and Interventions (4 papers), Epilepsy research and treatment (2 papers), Drug Transport and Resistance Mechanisms (2 papers), Pharmacogenetics and Drug Metabolism (2 papers) and Adenosine and Purinergic Signaling (1 paper). The work is most often cited by research in Virology (190 citations), Infectious Diseases (331 citations) and Pediatrics, Perinatology and Child Health (277 citations). Richard Granneman has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Joseph M. Machinist, J. W. Kesterson, Emil Samara, Ann Hsu, John M. Leonard, Allen Cato, John H. Cavanaugh, David D. Ho, Harry Shi and John C. Cavanaugh. Their work appears in journals such as Hepatology, Antimicrobial Agents and Chemotherapy and Clinical Pharmacology & Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.